ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,562 | -15.9% | 176,139 | -4.7% | 0.00% | – |
| Q2 2023 | $425,282 | -62.4% | 184,905 | -50.5% | 0.00% | – |
| Q1 2023 | $1,131,506 | +162.2% | 373,434 | +101.6% | 0.00% | – |
| Q4 2022 | $431,535 | +20.9% | 185,208 | -0.8% | 0.00% | – |
| Q3 2022 | $357,000 | -19.4% | 186,776 | +14.4% | 0.00% | – |
| Q2 2022 | $443,000 | -9.4% | 163,307 | -0.5% | 0.00% | – |
| Q1 2022 | $489,000 | – | 164,130 | +16412900.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
| Q1 2021 | $1,000 | -99.2% | 300 | -98.4% | 0.00% | – |
| Q3 2017 | $119,000 | +72.5% | 19,200 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +11.3% | 19,200 | 0.0% | 0.00% | – |
| Q1 2017 | $62,000 | +31.9% | 19,200 | 0.0% | 0.00% | – |
| Q4 2016 | $47,000 | -28.8% | 19,200 | 0.0% | 0.00% | – |
| Q3 2016 | $66,000 | -1.5% | 19,200 | 0.0% | 0.00% | – |
| Q2 2016 | $67,000 | -15.2% | 19,200 | 0.0% | 0.00% | – |
| Q1 2016 | $79,000 | -7.1% | 19,200 | 0.0% | 0.00% | – |
| Q4 2015 | $85,000 | +19.7% | 19,200 | +65.5% | 0.00% | – |
| Q3 2015 | $71,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Whitefort Capital Management, LP | 11,895,477 | $24,147,818 | 12.66% |
| Two Seas Capital LP | 8,280,818 | $16,810,061 | 3.38% |
| FourWorld Capital Management LLC | 1,341,907 | $2,724,071 | 0.51% |
| Tejara Capital Ltd | 180,077 | $365,556 | 0.21% |
| Woodline Partners LP | 4,719,903 | $9,581,403 | 0.11% |
| Hudson Bay Capital Management LP | 8,299,808 | $16,848,610 | 0.07% |
| Kepos Capital LP | 155,691 | $316 | 0.06% |
| Virtus ETF Advisers LLC | 40,040 | $81,281 | 0.05% |
| Centiva Capital, LP | 1,071,705 | $2,175,561 | 0.05% |
| Kades & Cheifetz LLC | 20,000 | $40,600 | 0.03% |